Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

about

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

Item

http://www.wikidata.org/entity/Q47105329

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@en

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@nl

type

Item

label

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@en

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@nl

prefLabel

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@en

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@nl

P1476

Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

@en

P2093

David G Benditt

http://www.w3.org/2001/XMLSchema#string

Ryan J Koene

http://www.w3.org/2001/XMLSchema#string

Wayne O Adkisson

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective Validation of the San Francisco Syncope Rule to Predict Patients With Serious Outcomes

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

Guidelines for the diagnosis and management of syncope (version 2009)

Infiltrative Cardiomyopathies

Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement

Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop

Syncope risk stratification tools vs clinical judgment: an individual patient data meta-analysis.

Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.

Diagnostic value of history in patients with syncope with or without heart disease.

Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy.

P304

533-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.JOA.2017.07.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29255498

http://www.w3.org/2001/XMLSchema#string

P932

5728985

http://www.w3.org/2001/XMLSchema#string